Erlotinib complexation with randomly methylated β-cyclodextrin improves drug solubility, intestinal permeability, and therapeutic efficacy in non-small cell lung cancer

N Erdoğar, S Akkın, G Varan… - Pharmaceutical …, 2021 - Taylor & Francis
The purpose of this study was to investigate the impact of anticancer drug erlotinib-randomly
methylated-β-cyclodextrin complex (ERL-RAMEB CD) on drug solubility and dissolution …
被引用次数：6 相关文章

Erlotinib complexation with randomly methylated β-cyclodextrin improves drug solubility, intestinal permeability, and therapeutic efficacy in non-small cell lung cancer.

N Erdoğar, S Akkın, G Varan… - Pharmaceutical …, 2021 - europepmc.org
The purpose of this study was to investigate the impact of anticancer drug erlotinib-randomly
methylated-β-cyclodextrin complex (ERL-RAMEB CD) on drug solubility and dissolution …

Erlotinib complexation with randomly methylated β-cyclodextrin improves drug solubility, intestinal permeability, and therapeutic efficacy in non-small cell lung cancer

N Erdoğar, S Akkın, G Varan… - Pharmaceutical …, 2021 - pubmed.ncbi.nlm.nih.gov
The purpose of this study was to investigate the impact of anticancer drug erlotinib-randomly
methylated-β-cyclodextrin complex (ERL-RAMEB CD) on drug solubility and dissolution …

Erlotinib complexation with randomly methylated beta-cyclodextrin improves drug solubility, intestinal permeability, and therapeutic efficacy in non-small cell lung …

N Erdogar, S Akkin, G VARAN… - PHARMACEUTICAL …, 2021 - avesis.hacettepe.edu.tr
The purpose of this study was to investigate the impact of anticancer drug erlotinib-randomly
methylated-beta-cyclodextrin complex (ERL-RAMEB CD) on drug solubility and dissolution …